Renal artery stenosis causes hypertension by triggering a hormonal chain reaction designed to raise blood pressure. When a renal artery narrows, the affected kidney senses reduced blood flow and responds as if the entire body’s blood pressure is too low. It releases a hormone called renin, which sets off a powerful system that constricts blood vessels, retains salt and water, and drives blood pressure up systemically.
The Pressure Drop That Starts Everything
Your kidneys have specialized pressure-sensing cells called juxtaglomerular cells, located in the walls of the tiny arteries that feed each filtering unit. When a renal artery narrows, less blood reaches the kidney, and these cells detect the drop in pressure. Simultaneously, a cluster of chemical sensors called the macula densa detects that less sodium is flowing past. Both signals converge on the same response: the kidney releases renin into the bloodstream.
Prostaglandins, which are local signaling molecules produced near the kidney’s filtering units, amplify this process. In a chronically underperfused kidney, production of these prostaglandins ramps up alongside renin, reinforcing the signal that blood flow is inadequate. The kidney essentially sounds an alarm that never turns off as long as the artery remains narrowed.
The Renin-Angiotensin-Aldosterone Cascade
Renin is an enzyme, and once it enters the bloodstream, it clips a larger protein made by the liver (angiotensinogen) into a smaller fragment called angiotensin I. That fragment is then converted into angiotensin II by another enzyme concentrated in the blood vessels of the lungs. Angiotensin II is one of the most potent blood-vessel-constricting substances the body produces. It narrows arteries throughout the body, immediately raising blood pressure.
Angiotensin II also triggers the adrenal glands to release aldosterone. This hormone tells the kidneys and colon to pull more sodium back into the bloodstream and dump potassium into the urine. Where sodium goes, water follows. The result is an increase in total blood volume, which pushes blood pressure even higher. So the system raises pressure two ways at once: tighter blood vessels and more fluid filling them.
Why the Other Kidney Can’t Compensate
When only one renal artery is narrowed, you might expect the healthy kidney on the other side to simply flush out the extra salt and water and bring pressure back to normal. It doesn’t. This puzzle was first explored in animal models by the physiologist Harry Goldblatt in the 1930s and has been studied extensively since.
The healthy kidney does stop making its own renin in response to the rising blood pressure. Under normal circumstances, it would also ramp up sodium excretion through a process called pressure natriuresis, where higher arterial pressure causes the kidney to release more salt and water. But research from the American Physiological Society has shown that the non-stenotic kidney mysteriously accumulates high levels of angiotensin II within its own tissue, even though it has stopped producing renin. This locally elevated angiotensin II constricts the kidney’s internal blood vessels, boosts sodium reabsorption in the kidney’s tubules, and heightens the sensitivity of a feedback mechanism that further limits salt excretion. The combined effect is a powerful brake on the kidney’s ability to offload sodium at normal pressures. The body essentially needs hypertension just to maintain adequate urine output from that “healthy” kidney.
One Narrowed Artery vs. Two
The clinical picture differs depending on whether the stenosis affects one kidney or both. With unilateral stenosis (one side), the scenario above plays out: the stenotic kidney overproduces renin, and the contralateral kidney retains sodium despite sensing high pressure. Fluid volume expands, but the body’s total renin levels may eventually normalize somewhat because the healthy kidney suppresses its own renin production.
With bilateral stenosis, or stenosis in a person who has only one functioning kidney, the situation is more dangerous. Both kidneys (or the sole kidney) are underperfused, so there is no contralateral kidney to attempt compensation. Renin and aldosterone levels stay persistently elevated, and sodium retention is more pronounced because every nephron in the body sits behind a narrowed artery. Blood pressure in these cases tends to be more severe and harder to control with medication.
What Causes the Artery to Narrow
Renal artery stenosis is the most common cause of secondary hypertension, meaning high blood pressure with an identifiable underlying cause. The vast majority of cases result from atherosclerosis, the same plaque buildup that causes heart attacks and strokes. These patients are typically older, often with diabetes, high cholesterol, or a history of smoking.
A smaller subset, roughly 10% to 20% of cases, is caused by fibromuscular dysplasia (FMD), a condition where the artery wall develops abnormal fibrous tissue rather than plaque. FMD overwhelmingly affects women, with female-to-male ratios reported between 3:1 and 9:1 depending on the registry. The median age at diagnosis is 48, though it can appear in children or older adults. Caucasians are more frequently affected than Black individuals. Because FMD tends to strike younger women who wouldn’t otherwise be expected to have high blood pressure, its presence is an important clue during workup.
How It’s Detected
Doctors typically suspect renal artery stenosis when blood pressure is unusually resistant to standard medications, when it appears suddenly in a young woman or in an older patient with widespread vascular disease, or when kidney function declines without a clear explanation. The first-line imaging test is a duplex ultrasound of the renal arteries. Sonographers measure the speed of blood flow through the artery; a peak velocity above 200 cm per second generally indicates a hemodynamically significant narrowing, though thresholds between 100 and 200 cm/sec are reported across different diagnostic criteria. CT angiography or MR angiography can provide more detailed images when ultrasound results are inconclusive.
Why Treatment Requires Caution
The instinct might be to simply open the narrowed artery, but treatment decisions depend heavily on the clinical scenario. Medications that block the renin-angiotensin system, such as ACE inhibitors and angiotensin receptor blockers, are effective at lowering blood pressure in unilateral stenosis because they counteract the very hormone driving the problem. However, these same drugs can be dangerous in bilateral stenosis or in someone with a single functioning kidney.
Here’s why: when blood flow to the kidney is reduced by stenosis, angiotensin II plays a critical role in maintaining the kidney’s ability to filter blood. It preferentially tightens the tiny artery leaving the filtering unit (the efferent arteriole), which props up pressure inside the filter itself. If you block angiotensin II with medication in a kidney that depends on this mechanism to function, filtration pressure collapses and kidney function can decline acutely. For patients with bilateral disease, doctors typically rely on other classes of blood pressure medication and monitor kidney function closely.
Procedures to physically open the artery, such as balloon angioplasty with or without stenting, are generally reserved for patients whose blood pressure cannot be controlled with medications, whose kidney function is deteriorating, or who develop episodes of sudden fluid buildup in the lungs. Large clinical trials have shown that for many patients with atherosclerotic renal artery stenosis, medications alone perform comparably to stenting in terms of blood pressure control and kidney preservation. FMD, on the other hand, often responds well to angioplasty, particularly in younger patients.